SCOUT Report – New Clinical Data Reinforce the Accuracy and Reliability of SCOUT® Radar Localization System



New Clinical Data Reinforce the Accuracy and Reliability of SCOUT® Radar Localization System 

A Columbia University Medical Center study demonstrates low re-excision rates and no OR delays related to reflector placement
A clinical study evaluating the SCOUT® Radar Localization system in 100 patients undergoing breast lesion localization procedures has been published in the 
 journal. S
tudy results show that SCOUT is associated with acceptable margin positivity and low re-excision rates, with no postoperative complications identified.

The study was conducted in 100 women who underwent breast lesion localization and excision with SCOUT at Columbia University Medical Center between June 2015 and May 2016. A total of 123 reflectors were percutaneously placed into 111 breast targets using sonographic (n=40) or mammographic (n=83) guidance. Patients received one reflector (n=80), two reflectors (n=17) or three reflectors (n=3).
Key findings from the study include:
  • 100% of reflectors were successfully excised
  • The re-excision rate was 7.4% – which is lower than the 12-60% rate of positive margins reported with wire localization
  • No OR delays related to reflector placement
  • No complications of reflector placement
  • No postoperative complications

SCOUT Honored with Gold 2017 Medical Design Excellence Award as over 130 Hospitals adopt the technology 

The SCOUT® Radar Localization system has been honored with the 2017 Gold
Annual Medical Design Excellence Award (MDEA) in the “ER and OR Tools, Equipment and Supplies” category.
The MDEA is the premier awards program for the medical technology industry. Since its inception in 1998, the mission of the MDEA has been to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Products are judged based on design and engineering innovation, function and user-related innovation, patient benefits, business benefits and overall benefit to the healthcare system.
SCOUT has currently been adopted by more than 130 medical centers across the United States.  The Moores Cancer Center at UC San Diego Health was the milestone “100th Hospital” to implement SCOUT.  Anne M. Wallace, MD, director of the Comprehensive Breast Health Center at Moores Cancer Center commented on SCOUT:
“Our first priority is saving the lives of patients with cancer and, in the process, we strive to improve their radiological and surgical experiences.  With wire-free breast localization, there is a dual benefit. The surgeon can perform a more targeted operation that conserves healthy tissue while the patient experiences less discomfort and stress.”

US News & World Report: 
21st Century Approaches for Advancing Breast Cancer Care

Denise Johnson Miller, MD, FACS, Medical Director of Breast Surgery for Meridian Cancer Care, NJ, discusses the burden breast cancer places on women and how technological advances are supporting improved outcomes and making the patient journey easier on the body and mind: 
“Technology, though, isn’t just about making life easier; it’s about making life better. And that requires improving health outcomes and making disease management less burdensome.” 
We’re excited to share the full article, which features both SCOUT and APBI Brachytherapy:

This e-newsletter is brought to you by Cianna  Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.